In yesterday’s article, I reviewed the immensely concerning data that emerged throughout the SSRI antidepressant trials. Sadly, rather than this data being listened to, it was given a pass by the FDA, a pattern we have tragically seen occur with numerous highly lucrative pharmaceuticals. In my eyes, three things stand out about the SSRI saga.… Read More: Just How Far Will the FDA Go to Protect a… »
WASHINGTON — COVID-19 vaccine makers told Congress on Tuesday to expect a big jump in the delivery of doses over the coming month, and the companies insist they will be able to provide enough for most Americans to get inoculated by summer. By the end of March, Pfizer and Moderna expect to have provided the… Read More: Drug executives: Big jump in vaccine supply is coming soon »
Liberal backbencher Craig Kelly has demanded MPs “read the facts” on hydroxychloroquine during an outburst in federal parliament. The member for Hughes was shut down on Thursday after trying to get a medical journal about the anti-malaria drug tabled. Mr Kelly has been criticised during the coronavirus pandemic for his online rants about the treatment… Read More: ‘Read the facts’: MP pushes anti-malaria drug »
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Harvard-afilliated Massachusetts General Hospital (MGH)… Read More: New drug prolongs ALS patient survival in trial »